A record $51.3 billion (£38.1bn) has been invested in global healthtech this year, up 280% on 2016 levels.
The COVID-19 pandemic has catalysed investment in an already growing healthtech sector, with new funding highs reached for companies using technology to improve research, delivery, payment and consumption of care.
The US leads globally with $31.9 billion (£23.7bn) in venture capital...
